Ferguson Wellman Capital Management Inc. bought a new stake in Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 76,975 shares of the technology company's stock, valued at approximately $27,821,000. Ferguson Wellman Capital Management Inc. owned about 0.07% of Celestica as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Renaissance Technologies LLC purchased a new stake in Celestica in the 1st quarter worth about $68,952,000. K.J. Harrison & Partners Inc purchased a new stake in Celestica during the second quarter valued at about $1,092,000. Quantinno Capital Management LP lifted its holdings in Celestica by 73.7% during the first quarter. Quantinno Capital Management LP now owns 23,954 shares of the technology company's stock valued at $6,746,000 after purchasing an additional 10,164 shares during the last quarter. Ninepoint Partners LP bought a new position in Celestica during the second quarter worth about $2,880,000. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Celestica by 1.9% in the first quarter. The Manufacturers Life Insurance Company now owns 959,586 shares of the technology company's stock worth $270,416,000 after purchasing an additional 18,105 shares in the last quarter. 67.38% of the stock is owned by institutional investors.
Insider Activity at Celestica
In related news, President Todd Cooper sold 20,118 shares of Celestica stock in a transaction on Wednesday, September 23rd. The shares were sold at an average price of $360.00, for a total value of $7,242,480.00. Following the transaction, the president owned 73,252 shares in the company, valued at $26,370,720. This trade represents a 21.55% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Robert Mionis sold 98,453 shares of Celestica stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $368.99, for a total value of $36,328,172.47. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 243,067 shares of company stock valued at $89,200,967. Insiders own 1.10% of the company's stock.
Analyst Upgrades and Downgrades
CLS has been the topic of a number of recent research reports. UBS Group upgraded shares of Celestica from a "neutral" rating to a "buy" rating and upped their price target for the company from $410.00 to $430.00 in a research note on Monday, August 24th. Wolfe Research lifted their price objective on shares of Celestica from $425.00 to $475.00 and gave the company an "outperform" rating in a research note on Wednesday, July 29th. JPMorgan Chase & Co. raised their price target on Celestica from $445.00 to $485.00 and gave the stock an "overweight" rating in a report on Wednesday, July 29th. Bank of America reiterated a "buy" rating on shares of Celestica in a research note on Wednesday, July 29th. Finally, Weiss Ratings cut shares of Celestica from a "buy (b)" rating to a "buy (b-)" rating in a research note on Thursday, August 13th. Twenty-three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $450.50.
Get Our Latest Stock Report on Celestica
Celestica Price Performance
CLS traded down $2.12 during trading on Monday, reaching $385.19. The stock had a trading volume of 653,625 shares, compared to its average volume of 2,420,680. The business has a 50-day moving average of $330.45 and a 200-day moving average of $345.99. Celestica, Inc. has a one year low of $230.24 and a one year high of $474.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.68 and a current ratio of 1.23. The stock has a market cap of $44.29 billion, a PE ratio of 40.02 and a beta of 2.01.
Celestica (NYSE:CLS - Get Free Report) TSE: CLS last posted its quarterly earnings data on Monday, July 27th. The technology company reported $2.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.29 by $0.25. The firm had revenue of $4.68 billion during the quarter, compared to analysts' expectations of $4.30 billion. Celestica had a return on equity of 39.96% and a net margin of 7.16%.The company's revenue for the quarter was up 62.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.39 EPS. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. As a group, equities research analysts anticipate that Celestica, Inc. will post 10.71 EPS for the current fiscal year.
About Celestica
(
Free Report)
Celestica Inc NYSE: CLS is a global provider of design, manufacturing, and supply-chain services for original equipment manufacturers and other technology companies. The company helps customers develop, produce, deploy, and support complex hardware and electronic systems, serving industries such as communications, enterprise technology, aerospace and defense, industrial technology, health care, and semiconductor equipment.
Its services include product design and engineering, printed circuit board and systems assembly, manufacturing, testing, logistics, aftermarket support, and supply-chain management.
Further Reading
Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.